FDA Drug Application (203059) for LEVETIRACETAM by SUN PHARMA GLOBAL

Back to FDA Applications sponsored by SUN PHARMA GLOBAL

Application Number203059
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVETIRACETAM
Active IngredientLEVETIRACETAM

Active IngredientCount
List of drugs with Active Ingredient LEVETIRACETAM5


Back to FDA Applications sponsored by SUN PHARMA GLOBAL